Site Maintenance will take place from 4:00 PM on 2024-04-29 to 9:00 AM on 2024-05-01.
Please do not make any content change during this time, otherwise all the changes will be lost.

Select Publications

Preprints

Koirala A; McRae J; Britton PN; Downes M; Prasad SA; Nicholson S; Winkler NE; O’Sullivan MVN; Gondalwala F; Castellano C; Carey E; Hendry A; Crawford N; Wadia U; Richmond P; Marshall HS; Clark JE; Francis JR; Carr J; Bartlett A; McMullan B; Skowno J; Hannah D; Davidson A; von Ungern-Sternberg BS; Lee-Archer P; Burgoyne LL; Waugh EB; Carlin JB; Naing Z; Kerly N; McMinn A; Hunter G; Heath C; D’Angelo N; Finucane C; Francis LA; Dougherty S; Rawlinson W; Karapanagiotidis T; Cain N; Brizuela R; Blyth CC; Wood N; Macartney K, 2024, The seroprevalence of SARS-CoV-2-specific antibodies in Australian children: a cross sectional study, , http://dx.doi.org/10.1101/2024.03.03.24303672

Foster CSP; Walker GJ; Jean T; Wong M; Brassil L; Isaacs S; Lyu Y; Turville S; Kelleher A; Rawlinson WD, 2023, Long-term serial passaging of SARS-CoV-2 reveals signatures of convergent evolution, , http://dx.doi.org/10.1101/2023.11.02.565396

Zufan S; Lau K; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson W; Ballard S; Stinear T; Howden B; Jennison A; Seemann T, 2023, Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance, , http://dx.doi.org/10.1101/2023.02.01.526694

Akerman A; Milogiannakis V; Jean T; Esneau C; Silva MR; Ison T; Fitcher C; Lopez JA; Chandra D; Naing Z; Caguicla J; Li D; Walker G; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Condylios A; Yeang M; Wong M; Foster CSP; Sato K; Lee S; Song Y; Mao L; Sigmund A; Phu A; Vande More AM; Hunt S; Douglas M; Caterson I; Sandgren K; Bull R; Lloyd A; Triccas J; Tangye S; Bartlett NW; Darley D; Matthews G; Stark DJ; Rawlinson WD; Murrell B; Brilot F; Cunningham AL; Kelleher AD; Aggarwal A; Turville SG, 2022, Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sublineages in the face of maturing antibody breadth at the population level, , http://dx.doi.org/10.1101/2022.12.06.22283000

Schütz M; Müller R; Socher E; Wangen C; Full F; Wyler E; Wong D; Scherer M; Stamminger T; Chou S; Rawlinson WD; Hamilton ST; Sticht H; Marschall M, 2022, Highly conserved interaction profiles between clinically relevant mutants of the cytomegalovirus CDK-like kinase pUL97 and human cyclins: functional significance of cyclin H, , http://dx.doi.org/10.21203/rs.3.rs-1676959/v1

Aggarwal A; Stella A; Akerman A; Walker G; Milogiannakis V; McAllery S; Esneau C; Silva MR; Lu Y; Forster C; Hal SV; Mathivanan V; Fitcher C; Hoppe AC; Munier ML; Darley D; Matthews G; Starck D; Robosa R; Bartlett N; Rawlinson W; Kelleher A; Turville S, 2022, Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants, , http://dx.doi.org/10.21203/rs.3.rs-1210846/v1

Rouet R; Henry J; Johansen M; Sobti M; Balachandran H; Langley D; Walker G; Lenthall H; Jackson J; Ubiparipovic S; Mazigi O; Schofield P; Burnett D; Brown S; Martinello M; Hudson B; Gilroy N; Post J; Kelleher A; Jäck H-M; Goodnow C; Turville S; Rawlinson W; Bull R; Stewart A; Hansbro P; Christ D, 2022, Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients, , http://dx.doi.org/10.1101/2022.10.19.512954

Foster CSP; Bull R; Tedla N; Santiago F; Agapiou D; Adhikari A; Walker G; Shrestha LB; van Hal S; Kim KW; Rawlinson W, 2022, Persistence of a SARS-CoV-2 variant with a frameshifting deletion for the duration of a major outbreak, , http://dx.doi.org/10.1101/2022.09.06.22279658

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Coppola G; Yeang M; Jean T; Foster C; Hoppe AC; Ling Munier M; Darley D; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, 2022, SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, , http://dx.doi.org/10.1101/2022.07.07.22277128

Walker GJ; Davis R; Naing Z; McEntee B; Lu Y; Denadija T; Rawlinson WD, 2021, Serological detection of SARS-CoV-2 IgG using commercially available immunoassays on dried blood spots collected from patients, , http://dx.doi.org/10.1101/2021.08.11.21261877

Tennant E; Figtree M; Tallon J; Bull R; Yeang M; Deveson I; Ferguson J; Adikari T; Holmes E; Hal SV; Hammond J; Stevanovski I; Mitsakos K; Hilditch-Roberts D; Rawlinson W; Hudson B, 2021, Epidemiological and Genomic analysis of a Sydney Hospital COVID-19 Outbreak, , http://dx.doi.org/10.1101/2021.02.17.21251943

Adhikari A; Abayasingam A; Rodrigo C; Agapiou D; Pandzic E; Brasher N; Madushan Fernando BS; Keoshkerian E; Li H; Kim HN; Lord M; Popovic G; Rawlinson W; Mina M; Post J; Hudson B; Gilroy N; Bartlett A; Ahlenstiel G; Grubor-Bauk B; Dwyer D; Konecny P; Lloyd A; Martinello M; Bull R; Tedla N, 2021, Longitudinal characterisation of phagocytic and neutralisation functions of anti-Spike antibodies in plasma of patients after SARS-CoV-2 infection, , http://dx.doi.org/10.1101/2021.12.21.473774

Aggarwal A; Stella AO; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Henry J; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fichter C; Hoppe AC; Munier ML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2021, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, , http://dx.doi.org/10.1101/2021.12.14.21267772

Roth-Schulze A; Penno M; Ngui K; Oakey H; Bandala-Sanchez E; Smith A; Allnutt T; Thomson R; Vuillermin P; Craig M; Rawlinson W; Davis E; Harris M; Soldatos G; Colman P; Wentworth J; Haynes A; Morahan G; Bediaga N; Smyth G; Papenfuss A; Couper J; Harrison L, 2021, Type 1 Diabetes in Pregnancy Is Associated With Distinct Changes in the Composition and Function of the Gut Microbiome, , http://dx.doi.org/10.21203/rs.3.rs-376289/v1

Yeung VA; Thapa K; Rawlinson W; Georgiou A; Post J; Overton K, 2020, Differences in Antibiotic and Antiviral Use in People With Confirmed Influenza: a Retrospective Comparison of Rapid Influenza PCR and Multiplex Respiratory Virus PCR Tests., , http://dx.doi.org/10.21203/rs.3.rs-109807/v1

Lau KA; da Silva AG; Theis T; Gray J; Ballard SA; Rawlinson WD, 2020, Proficiency Testing for bacterial whole genome sequencing in assuring the quality of microbiology diagnostics in clinical and public health laboratories, , http://dx.doi.org/10.1101/2020.09.18.304519

Bull R; Adikari T; Ferguson J; Hammond J; Stevanovski I; Beukers A; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden J-S; Rawlinson W; van Hal S; Deveson I, 2020, Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis, , http://dx.doi.org/10.1101/2020.08.04.236893

Roth-Schulze A; Penno M; Ngui K; Oakey H; Thomson R; Vuillermin P; Craig M; Rawlinson W; Davis E; Harris M; Soldatos G; Colman P; Wentworth J; Haynes A; Morahan G; Bediaga N; Smyth G; Papenfuss A; Couper J; Harrison L, 2020, Changes in the composition and function of the gut microbiome accompany type 1 diabetes in pregnancy, , http://dx.doi.org/10.21203/rs.3.rs-18520/v1

Madala BS; Reis A; Deveson I; Rawlinson W; Mercer T, 2020, Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests, , http://dx.doi.org/10.1101/2020.06.09.143412

Isaacs SR; Roy A; Dance B; Ward EJ; Foskett DB; Maxwell AJ; Rawlinson W; Kim KW; Craig ME, Enterovirus Infection and Risk of Islet Autoimmunity and Type 1 Diabetes: Systematic Review and Meta-Analysis of Molecular Studies, , http://dx.doi.org/10.2139/ssrn.4308770

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Yeang M; Jean T; Foster C; Hoppe AC; Munier ML; Darley DR; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern, , http://dx.doi.org/10.2139/ssrn.4157473


Back to profile page